These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 16417650

  • 1. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ.
    Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
    [Abstract] [Full Text] [Related]

  • 2. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
    Journe F, Chaboteaux C, Dumon JC, Leclercq G, Laurent G, Body JJ.
    Br J Cancer; 2004 Nov 01; 91(9):1703-10. PubMed ID: 15477866
    [Abstract] [Full Text] [Related]

  • 3. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V, Jensen EV, Knabbe C.
    Cancer Res; 1998 Jan 15; 58(2):263-7. PubMed ID: 9443403
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA, Sager R, Webster L.
    Cancer Res; 1993 Oct 15; 53(20):5004-11. PubMed ID: 8402691
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
    Robertson JF, Nicholson RI, Bundred NJ, Anderson E, Rayter Z, Dowsett M, Fox JN, Gee JM, Webster A, Wakeling AE, Morris C, Dixon M.
    Cancer Res; 2001 Sep 15; 61(18):6739-46. PubMed ID: 11559545
    [Abstract] [Full Text] [Related]

  • 12. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH, Parker CJ, Jordan VC.
    Cancer Res; 1992 Dec 01; 52(23):6539-46. PubMed ID: 1423300
    [Abstract] [Full Text] [Related]

  • 13. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 01; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 14. Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line.
    Barrón-González A, Castro Romero I.
    Biochem Cell Biol; 2004 Apr 01; 82(2):335-42. PubMed ID: 15060629
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1992 Apr 01; 12(3):585-90. PubMed ID: 1622114
    [Abstract] [Full Text] [Related]

  • 19. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V, Gougelet A, Maillard S, Renoir JM.
    Mol Endocrinol; 2003 Oct 01; 17(10):2013-27. PubMed ID: 12855746
    [Abstract] [Full Text] [Related]

  • 20. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors.
    Harnagea-Theophilus E, Gadd SL, Knight-Trent AH, DeGeorge GL, Miller MR.
    Toxicol Appl Pharmacol; 1999 Mar 15; 155(3):273-9. PubMed ID: 10079213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.